The Cartagena Protocol on Biosafety that was adopted by governments on 29 January 2000 is the main international legally binding treaty that regulates ?the safe transfer, handling and use of living modified organisms resulting from modern biotechnology? that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health?.

It is significant as the first global treaty to attempt to contribute to the protection of biodiversity and human health in this field, and as the first treaty to operationalise the precautionary approach in decision-making relating to imports under the Protocol. As of 22 February 2005, there are 113 Parties to the Protocol.

Although the Protocol focuses on transboundary movements of GMOs, its provisions do influence national and regional biosafety policies and laws, bearing in mind that the Protocol sets minimum requirements and Parties have the right to formulate more comprehensive national laws with higher standards. This is reaffirmed in Article 2(4).

Meanwhile, work and standard setting are also taking place in other international fora, such as the Codex Alimentarius, the International Plant Protection Convention and the International Office of Epizootics, the UN Food and Agriculture Organisation and the World Health Organisation.

The linkages among trade, environment and health means that developments at the World Trade Organisation also impact on biosafety and vice versa.

A field of growing importance is the development of biological weapons as part of biodefence programmes where the adequacy of global rules and standards needs examinination.

The Cartagena Biosafety Protocol and the WTO agreements

The relationship between the Cartagena Protocol on Biosafety and the WTO agreements has yet to be settled. The following article examines how the WTO agreements impact on biosafety and the Cartagena Protocol. […]

The Cartagena Biosafety Protocol and the WTO agreements (Chinese)

The relationship between the Cartagena Protocol on Biosafety and the WTO agreements has yet to be settled. The following article examines how the WTO agreements impact on biosafety and the Cartagena Protocol. […]

TWN Briefing for Codex Alimentarius Commission

TWN assesses The Codex Alimentarius Commission’s Guidelines for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants and Foods Produced Using Recombinant-DNA Microorganisms […]

Capacity Building and the Biosafety Protocol: A TWN report

This paper is on the capacity building needs in developing countries to implement the Biosafety Protocol. It examines the key requirements for effective national implementation of the Protocol and makes specific recommendations on critical areas. […]

Biosafety talks end on mixed note

After five years of difficult and painful negotiations, the Parties to the UN Convention on Biological Diversity finally concluded a Biosafety Protocol in late January 2000 at Montreal. […]

Delayed, but better, Biosafety Protocol

Looking back, it is clear that the collapse of the biosafety negotiations in Cartagena was a blessing in disguise. […]

The ‘Cartagena/Vienna setting’: Towards more transparent and democratic global negotiations

While it was public pressure that finally pushed the negotiations in Montreal in 2000 to a successful conclusion, the process was greatly facilitated by the innovative and transparent procedures initiated by the chairman of the meeting, Minister Juan Mayr […]

Biosafety negotiations – flashbacks

Tewolde Berhan G Egziabher, the spokesperson of the Like-Minded Group (Group of 77 & China) at the Montreal and Cartagena talks and who has been involved in the biodiversity negotiations since the Nairobi Conference in 1991, reflects on his experience. […]

The core issues in the Biosafety Protocol: An analysis

Only the core issues of the Biosafety Protocol were negotiated at Montreal in 2000. The remaining provisions were basically the same as those negotiated at the earlier talks in Cartagena in 1999. Lim Li Lin analyses and comments on these core provisions. […]

The way forward

Now that the Biosafety Protocol has been negotiated, what are the steps that can be taken to fill in the gaps left by the Protocol? Some key dates and suggestions for consideration are set out below. […]